The editors of the prestigious journal Clinical Infectious Diseases have selected a study coordinated by the Infectious Diseases group at Vall d’Hebron Institute of Research (VHIR), to receive the Emanuel Wolinsky Award for the most outstanding clinical study published in the journal during 2013.The research, entitled "http://cid.oxfordjournals.org/content/56/9/1261.long" “Ampicillin Plus Ceftriaxone is As Effective As Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis (EFIE)”, was conducted through the "http://www.reipi.org/" Spanish network in infectious pathology (REIPI), and involved 17 Spanish hospitals and a Italian one. In this observational, nonrandomized and multicenter study, researchers demonstrated that a new antimicrobial pattern, made by Ampicillin plus ceftriaxone, appears as effective as ampicillin plus gentamicin for treating patients with enterococcus faecalis infective endocarditis. The main advantage of the new therapeutic harm is that can be used with virtually no risk of renal failure and regardless of the high-level aminoglycoside resistance status of E. faecalis. The editors of the journal highlighted that “this ambitious study provides useful clinical data in a field in which information is scarce and therapeutic alternatives are limited”. They also underlined that “it adds important data to the evolving paradigm of treating enterococcal IE and opens avenues for relevant clinical trials in the future”.VHIR researchers will receive the award on October 6th, at the ceremony of the "http://www.idsociety.org/Index.aspx" Infectious Diseases Society of American (IDSA) in Philadephia, USA. To date, any article written by Spanish researchers had obtained this award, endowed with 1,000 euros.